<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<?covid-19-tdm?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7989618</article-id>
    <article-id pub-id-type="pmid">33693506</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btab163</article-id>
    <article-id pub-id-type="publisher-id">btab163</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Original Paper</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>COVID-19: disease pathways and gene expression changes predict methylprednisolone can improve outcome in severe cases</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Draghici</surname>
          <given-names>Sorin</given-names>
        </name>
        <xref ref-type="corresp" rid="btab163-cor1"/>
        <xref ref-type="aff" rid="btab163-aff1">1</xref>
        <xref ref-type="aff" rid="btab163-aff2">2</xref>
        <xref ref-type="aff" rid="btab163-aff5">5</xref>
        <!--<email>sorin@wayne.edu</email>-->
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Nguyen</surname>
          <given-names>Tuan-Minh</given-names>
        </name>
        <xref ref-type="aff" rid="btab163-aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Sonna</surname>
          <given-names>Larry A</given-names>
        </name>
        <xref ref-type="aff" rid="btab163-aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ziraldo</surname>
          <given-names>Cordelia</given-names>
        </name>
        <xref ref-type="aff" rid="btab163-aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Vanciu</surname>
          <given-names>Radu</given-names>
        </name>
        <xref ref-type="aff" rid="btab163-aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Fadel</surname>
          <given-names>Raef</given-names>
        </name>
        <xref ref-type="aff" rid="btab163-aff5">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Morrison</surname>
          <given-names>Austin</given-names>
        </name>
        <xref ref-type="aff" rid="btab163-aff6">6</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kenney</surname>
          <given-names>Rachel M</given-names>
        </name>
        <xref ref-type="aff" rid="btab163-aff6">6</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Alangaden</surname>
          <given-names>George</given-names>
        </name>
        <xref ref-type="aff" rid="btab163-aff7">7</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ramesh</surname>
          <given-names>Mayur</given-names>
        </name>
        <xref ref-type="aff" rid="btab163-aff7">7</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Mor</surname>
          <given-names>Gil</given-names>
        </name>
        <xref ref-type="corresp" rid="btab163-cor1"/>
        <xref ref-type="aff" rid="btab163-aff2">2</xref>
        <!--<email>sorin@wayne.edu</email>-->
      </contrib>
    </contrib-group>
    <aff id="btab163-aff1"><label>1</label>Department of Computer Science, <institution>Wayne State University</institution>, Michigan 48202, <institution>USA</institution></aff>
    <aff id="btab163-aff2"><label>2</label>Department of Obstetrics and Gynecology, <institution>Wayne State University</institution>, Michigan 48202, <institution>USA</institution></aff>
    <aff id="btab163-aff3"><label>3</label><institution>Bon Air Consulting</institution>, <institution>USA</institution></aff>
    <aff id="btab163-aff4"><label>4</label><institution>Advaita Bioinformatics</institution>, <institution>USA</institution></aff>
    <aff id="btab163-aff5"><label>5</label>Department of Internal Medicine, <institution>Henry Ford Health System</institution>, <institution>USA</institution></aff>
    <aff id="btab163-aff6"><label>6</label>Department of Pharmacy, <institution>Henry Ford Health System</institution>, <institution>USA</institution></aff>
    <aff id="btab163-aff7"><label>7</label>Division of Infectious Diseases, <institution>Henry Ford Health System</institution>, <country country="US">USA</country></aff>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Kelso</surname>
          <given-names>Janet</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="btab163-cor1">To whom correspondence should be addressed. Email: <email>sorin@wayne.edu</email> and <email>gmor@med.wayne.edu</email></corresp>
    </author-notes>
    <pub-date pub-type="epub" iso-8601-date="2021-03-09">
      <day>09</day>
      <month>3</month>
      <year>2021</year>
    </pub-date>
    <elocation-id>btab163</elocation-id>
    <history>
      <date date-type="received">
        <day>25</day>
        <month>11</month>
        <year>2020</year>
      </date>
      <date date-type="rev-recd">
        <day>15</day>
        <month>2</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>04</day>
        <month>3</month>
        <year>2021</year>
      </date>
      <date date-type="editorial-decision">
        <day>01</day>
        <month>3</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Â© The Author(s) (2021). Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com</copyright-statement>
      <copyright-year>2021</copyright-year>
      <license>
        <license-p>This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.</license-p>
      </license>
      <license license-type="publisher-standard" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">
        <license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</ext-link>)</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btab163.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Motivation</title>
        <p>COVID-19 has several distinct clinical phases: a viral replication phase, an inflammatory phase, and in some patients, a hyper-inflammatory phase. High mortality is associated with patients developing cytokine storm syndrome. Treatment of hyper-inflammation in these patients using existing, approved therapies with proven safety profiles could address the immediate need to reduce mortality.</p>
      </sec>
      <sec id="s2">
        <title>Results</title>
        <p>We analyzed the changes in the gene expression, pathways and putative mechanisms induced by SARS-CoV2 in NHBE, and A549 cells, as well as COVID-19 lung vs. their respective controls. We used these changes to identify FDA approved drugs that could be repurposed to help COVID-19 patients with severe symptoms related to hyper-inflammation. We identified methylprednisolone (MP) as a potential leading therapy. The results were then confirmed in five independent validation data sets including Vero E6 cells, lung and intestinal organoids, as well as additional patient lung sample vs. their respective controls. Finally, the efficacy of MP was validated in an independent clinical study. Thirty-day all-cause mortality occurred at a significantly lower rate in the MP-treated group compared to control group (29.6% vs. 16.6%, <italic>p</italic> = 0.027). Clinical results confirmed the <italic>in silico</italic> prediction that MP could improve outcomes in severe cases of COVID-19. A low number needed to treat (<italic>NNT</italic> = 5) suggests MP may be more efficacious than dexamethasone or hydrocortisone.</p>
      </sec>
      <sec id="s3">
        <title>Availability</title>
        <p>iPathwayGuide is available at <ext-link ext-link-type="uri" xlink:href="https://ipathwayguide.advaitabio.com/">https://ipathwayguide.advaitabio.com/</ext-link></p>
      </sec>
      <sec id="s4">
        <title>Supplementary information</title>
        <p>Supplementary data are available at <italic>Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <counts>
      <page-count count="9"/>
    </counts>
    <custom-meta-group>
      <custom-meta>
        <meta-name>edited-state</meta-name>
        <meta-value>accepted-manuscript</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>article-lifecycle</meta-name>
        <meta-value>PAP</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
